beta

AMAG

AMAG Pharmaceuticals Inc.

Amag

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-01-2018 08-02-2018 05-03-2018 02-27-2018 11-02-2017 08-03-2017 05-02-2017
Actual EPS -0.77 -0.75 -1.59 0.1 1.57 -0.4 -1.06
Consensus EPS -0.77 -0.21 -0.49 -0.58 -0.04 -0.58 0.09
Estimated EPS -0.77 -0.21 -0.49 -0.58 -0.04 -0.58 0.09
Number of Estimates 4 4 4 3 5 4 4
EPS Surprise -$0.54 -$1.10 $0.68 $1.61 $0.18 -$1.15

Stats

Summary

AMAG Pharmaceuticals Inc is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and to aid in the diagnosis of cancer.

Market Cap: 518 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.amagpharma.com

Shares Outstanding: 35.4 Million

Float: 34 Million

Dividend: 0.0 (0.0%)

Beta: 0.826016

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 8.33 Million

Ethical Flags

Animal testing

Longest drawdown: 854 trading days

From: 2015-07-16 To: 2018-12-14

Lowest Point:

Antares Pharma: Growth Story At A 20th Century Price

via: SeekingAlpha at 2018-12-17 01:32:14:000

Microcap stocks, especially biotechs, can take years to play out for investors. With Antares Pharma ( ATRS ), it has taken decades. Accordingly, covering two decades, the chart below does not provide any technical encouragement. The companys roots actually go back to 1979 and, as much … read more...

AMAG Pharmaceuticals, Inc. (AMAG) CEO William Heiden on Acquisition of Perosphere Pharmaceuticals (Transcript)

via: SeekingAlpha at 2018-12-13 13:51:09:000

AMAG Pharmaceuticals, Inc. (AMAG) AMAG Acquires Perosphere Pharmaceuticals Inc. Conference Call December 13, 2018 08:00 AM ET Executives Linda Lennox - Vice President, Investor Relations and Corporate Communications William Heiden - President and Chief Executive Officer Julie K… read more...

AMAG Pharmaceuticals, Inc. (AMAG) CEO William Heiden on Acquisition of Perosphere Pharmaceuticals (Transcript)

via: SeekingAlpha at 2018-12-13 13:51:09:000

AMAG Pharmaceuticals, Inc. (AMAG) AMAG Acquires Perosphere Pharmaceuticals Inc. Conference Call December 13, 2018 08:00 AM ET Executives Linda Lennox - Vice President, Investor Relations and Corporate Communications William Heiden - President and Chief Executive Officer Julie K… read more...

AMAG Pharmaceuticals, Inc. (AMAG) CEO William Heiden on Acquisition of Perosphere Pharmaceuticals (Transcript)

via: SeekingAlpha at 2018-12-13 13:51:09:000

AMAG Pharmaceuticals, Inc. (AMAG) AMAG Acquires Perosphere Pharmaceuticals Inc. Conference Call December 13, 2018 08:00 AM ET Executives Linda Lennox - Vice President, Investor Relations and Corporate Communications William Heiden - President and Chief Executive Officer Julie K… read more...

AMAG Pharmaceuticals to acquire Perosphere Pharmaceuticals

via: SeekingAlpha at 2018-12-13 06:45:18:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has entered into a definitive agreement to acquire Perosphere Pharmaceuticals, a private biopharmaceutical company. Through this acquisition, AMAG will acquire global rights to ciraparantag. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks … read more...

AMAG Pharmaceuticals to acquire Perosphere Pharmaceuticals

via: SeekingAlpha at 2018-12-13 06:45:18:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has entered into a definitive agreement to acquire Perosphere Pharmaceuticals, a private biopharmaceutical company. Through this acquisition, AMAG will acquire global rights to ciraparantag. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks … read more...

AMAG Pharmaceuticals to acquire Perosphere Pharmaceuticals

via: SeekingAlpha at 2018-12-13 06:45:18:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has entered into a definitive agreement to acquire Perosphere Pharmaceuticals, a private biopharmaceutical company. Through this acquisition, AMAG will acquire global rights to ciraparantag. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks … read more...

Why I Sold Antares Pharma

via: SeekingAlpha at 2018-12-04 17:05:41:000

For the first time in over 6 years, I no longer own shares of Antares Pharma ( ATRS ). It's certainly been a wild ride and I'm grateful for the many investors I've gotten to know and converse with. But with the decision to sell all my shares - in lieu of just reducing as I've done in the past … read more...

Why I Sold Antares Pharma

via: SeekingAlpha at 2018-12-04 17:05:41:000

For the first time in over 6 years, I no longer own shares of Antares Pharma ( ATRS ). It's certainly been a wild ride and I'm grateful for the many investors I've gotten to know and converse with. But with the decision to sell all my shares - in lieu of just reducing as I've done in the past … read more...

Why I Sold Antares Pharma

via: SeekingAlpha at 2018-12-04 17:05:41:000

For the first time in over 6 years, I no longer own shares of Antares Pharma ( ATRS ). It's certainly been a wild ride and I'm grateful for the many investors I've gotten to know and converse with. But with the decision to sell all my shares - in lieu of just reducing as I've done in the past … read more...

Why I Sold Antares Pharma

via: SeekingAlpha at 2018-12-04 17:05:41:000

For the first time in over 6 years, I no longer own shares of Antares Pharma ( ATRS ). It's certainly been a wild ride and I'm grateful for the many investors I've gotten to know and converse with. But with the decision to sell all my shares - in lieu of just reducing as I've done in the past … read more...

AMAG Pharmaceuticals: Q3 Results Top Or Flop?

via: SeekingAlpha at 2018-11-07 13:05:26:000

On Thursday, November 1, 2018, AMAG Pharmaceuticals (AMAG) announced its third quarter earnings results . Overall, the company remains in a position to deliver solid growth going forward due to a number of reasons: (1) improved liquidity position despite some downside risks; (2) the company h… read more...

AMAG Pharmaceuticals: Q3 Results Top Or Flop?

via: SeekingAlpha at 2018-11-07 13:05:26:000

On Thursday, November 1, 2018, AMAG Pharmaceuticals (AMAG) announced its third quarter earnings results . Overall, the company remains in a position to deliver solid growth going forward due to a number of reasons: (1) improved liquidity position despite some downside risks; (2) the company h… read more...

AMAG Pharmaceuticals: Q3 Results Top Or Flop?

via: SeekingAlpha at 2018-11-07 13:05:26:000

On Thursday, November 1, 2018, AMAG Pharmaceuticals (AMAG) announced its third quarter earnings results . Overall, the company remains in a position to deliver solid growth going forward due to a number of reasons: (1) improved liquidity position despite some downside risks; (2) the company h… read more...

Citi soft on Solid Biosciences in premarket healthcare analyst action

via: SeekingAlpha at 2018-11-06 08:33:42:000

Alder Biopharmaceuticals (NASDAQ: ALDR ) resumed with Outperform rating and $36 (153% upside) price target at Wells Fargo. More news on: Alder Biopharmaceuticals Inc., Solid Biosciences, Inc., AMAG Pharmaceuticals, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the m… read more...

Piper frets supply risks for AMAG's Makena

via: SeekingAlpha at 2018-11-02 18:18:41:000

Piper Jaffray is warning about potential downside after reviewing AMAG Pharmaceuticals' (NASDAQ: AMAG ) 10-Q filing from this morning . More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more … read more...

Piper frets supply risks for AMAG's Makena

via: SeekingAlpha at 2018-11-02 18:18:41:000

Piper Jaffray is warning about potential downside after reviewing AMAG Pharmaceuticals' (NASDAQ: AMAG ) 10-Q filing from this morning . More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more … read more...

Piper frets supply risks for AMAG's Makena

via: SeekingAlpha at 2018-11-02 18:18:41:000

Piper Jaffray is warning about potential downside after reviewing AMAG Pharmaceuticals' (NASDAQ: AMAG ) 10-Q filing from this morning . More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more … read more...

Piper frets supply risks for AMAG's Makena

via: SeekingAlpha at 2018-11-02 18:18:41:000

Piper Jaffray is warning about potential downside after reviewing AMAG Pharmaceuticals' (NASDAQ: AMAG ) 10-Q filing from this morning . More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more … read more...

AMAG Pharmaceuticals, Inc. (AMAG) CEO William Heiden on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-01 13:42:08:000

AMAG Pharmaceuticals, Inc. (AMAG) Q3 2018 Results Earnings Conference Call November 1, 2018, 08:00 AM ET Executives Linda Lennox - Vice President, Investor Relations and Corporate Communications William Heiden - President and Chief Executive Officer Nicholas Grund - Executive Vic… read more...

AMAG Pharmaceuticals, Inc. (AMAG) CEO William Heiden on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-01 13:42:08:000

AMAG Pharmaceuticals, Inc. (AMAG) Q3 2018 Results Earnings Conference Call November 1, 2018, 08:00 AM ET Executives Linda Lennox - Vice President, Investor Relations and Corporate Communications William Heiden - President and Chief Executive Officer Nicholas Grund - Executive Vic… read more...

AMAG Pharmaceuticals, Inc. (AMAG) CEO William Heiden on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-01 13:42:08:000

AMAG Pharmaceuticals, Inc. (AMAG) Q3 2018 Results Earnings Conference Call November 1, 2018, 08:00 AM ET Executives Linda Lennox - Vice President, Investor Relations and Corporate Communications William Heiden - President and Chief Executive Officer Nicholas Grund - Executive Vic… read more...

Fitbit, Clovis Oncology and FreightCar America among midday movers (11.01.2018)

via: SeekingAlpha at 2018-11-01 12:39:07:000

More news on: SELLAS Life Sciences Group, Inc., Globus Maritime Ltd., FormFactor, Inc., Stocks on the move, , Read more … read more...

Fitbit, Clovis Oncology and FreightCar America among midday movers (11.01.2018)

via: SeekingAlpha at 2018-11-01 12:39:07:000

More news on: SELLAS Life Sciences Group, Inc., Globus Maritime Ltd., FormFactor, Inc., Stocks on the move, , Read more … read more...

Fitbit, Clovis Oncology and FreightCar America among midday movers (11.01.2018)

via: SeekingAlpha at 2018-11-01 12:39:07:000

More news on: SELLAS Life Sciences Group, Inc., Globus Maritime Ltd., FormFactor, Inc., Stocks on the move, , Read more … read more...

AMAG Pharmaceuticals, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-11-01 11:45:59:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

AMAG Pharmaceuticals, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-11-01 11:45:59:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

AMAG Pharmaceuticals, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-11-01 11:45:59:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

AMAG Pharma Q3 top line down 2%; non-GAAP EBITDA down 34%; shares down 16%

via: SeekingAlpha at 2018-11-01 10:42:18:000

AMAG Pharmaceuticals ( AMAG -15.5% ) slumps on more than double normal volume after releasing Q3 results this morning that included a 1.7% drop in revenue. Highlights: More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, … read more...

AMAG Pharmaceuticals misses by $1.10, beats on revenue

via: SeekingAlpha at 2018-11-01 07:07:46:000

AMAG Pharmaceuticals (NASDAQ: AMAG ): Q3 GAAP EPS of -$1.88 misses by $1.10 . More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-10-31 17:30:40:000

AAON , AAWW , ABMD , AGIO , ALE , AMAG , AMCX , AME , AMRN , ARES , AROC , ARW , AVP , AYR , BCE , BID , BLL , BMCH , BSIG , CBRE , CCOI , CEIX , CHD , CHSP , CI , CJ , CNQ , CNSL , CWT , D , DM , DNOW , DWDP , EEX , EGRX , EPAM , EXC , EXLS , FLWS , F… read more...

Palatin Technologies: Prepare For The New Female Viagra

via: SeekingAlpha at 2018-10-25 13:00:01:000

Palatin Technologies ( PTN ) is the biopharmaceutical company that has successfully developed bremelanotide, a drug that deals with problem of hypoactive sexual desire disorder (HSDD) in women. bremelanotide is expected to receive FDA approval in early 2019, which would generate large source o… read more...

Palatin Technologies: Prepare For The New Female Viagra

via: SeekingAlpha at 2018-10-25 13:00:01:000

Palatin Technologies ( PTN ) is the biopharmaceutical company that has successfully developed bremelanotide, a drug that deals with problem of hypoactive sexual desire disorder (HSDD) in women. bremelanotide is expected to receive FDA approval in early 2019, which would generate large source o… read more...

Palatin Technologies: Prepare For The New Female Viagra

via: SeekingAlpha at 2018-10-25 13:00:01:000

Palatin Technologies ( PTN ) is the biopharmaceutical company that has successfully developed bremelanotide, a drug that deals with problem of hypoactive sexual desire disorder (HSDD) in women. bremelanotide is expected to receive FDA approval in early 2019, which would generate large source o… read more...

Bulletproof Investing Performance Update: Week 46

via: SeekingAlpha at 2018-10-21 22:58:51:000

Safety first: NASCAR driver Johanna Long and her helmet (via Autowise ) Bulletproof Investing: Week 46 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This is an "… read more...

Bulletproof Investing Performance Update: Week 46

via: SeekingAlpha at 2018-10-21 22:58:51:000

Safety first: NASCAR driver Johanna Long and her helmet (via Autowise ) Bulletproof Investing: Week 46 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This is an "… read more...

Bulletproof Investing Performance Update: Week 46

via: SeekingAlpha at 2018-10-21 22:58:51:000

Safety first: NASCAR driver Johanna Long and her helmet (via Autowise ) Bulletproof Investing: Week 46 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This is an "… read more...

Why Antares Pharma Stock Dropped And What Is The Likely Outcome

via: SeekingAlpha at 2018-10-03 06:42:58:000

Monday, October 1 delivered a crushing blow for many Antares Pharma ( ATRS ) investors as the stock got hammered 3% after the company announced early Monday that it had received FDA approval for its biggest opportunity, Xyosted, a first-line therapy for low testosterone. Trading 6.4 million … read more...

Why Antares Pharma Stock Dropped And What Is The Likely Outcome

via: SeekingAlpha at 2018-10-03 06:42:58:000

Monday, October 1 delivered a crushing blow for many Antares Pharma ( ATRS ) investors as the stock got hammered 3% after the company announced early Monday that it had received FDA approval for its biggest opportunity, Xyosted, a first-line therapy for low testosterone. Trading 6.4 million … read more...

Why Antares Pharma Stock Dropped And What Is The Likely Outcome

via: SeekingAlpha at 2018-10-03 06:42:58:000

Monday, October 1 delivered a crushing blow for many Antares Pharma ( ATRS ) investors as the stock got hammered 3% after the company announced early Monday that it had received FDA approval for its biggest opportunity, Xyosted, a first-line therapy for low testosterone. Trading 6.4 million … read more...

AMAG Pharmaceuticals acquires Orphan Drug candidate for treatment of severe preeclampsia

via: SeekingAlpha at 2018-09-26 06:58:28:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has acquired global rights to develop and market digoxin immune Fab (ovine) (DIF), a polyclonal antibody in development for the treatment of severe preeclampsia in pregnant women. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, R… read more...

AMAG Pharmaceuticals acquires Orphan Drug candidate for treatment of severe preeclampsia

via: SeekingAlpha at 2018-09-26 06:58:28:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has acquired global rights to develop and market digoxin immune Fab (ovine) (DIF), a polyclonal antibody in development for the treatment of severe preeclampsia in pregnant women. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, R… read more...

AMAG Pharmaceuticals acquires Orphan Drug candidate for treatment of severe preeclampsia

via: SeekingAlpha at 2018-09-26 06:58:28:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has acquired global rights to develop and market digoxin immune Fab (ovine) (DIF), a polyclonal antibody in development for the treatment of severe preeclampsia in pregnant women. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, R… read more...

The Magic Formula Needs An Upgrade

via: SeekingAlpha at 2018-09-19 15:35:18:000

In this article I will first go into the basic principle behind the Magic Formula and the Value Investing approach: The Margin of Safety. I will describe in detail why a Margin of Safety is fundamental for becoming a successful investor, supplied with phrases from Benjamin Graham's famous book… read more...

The Magic Formula Needs An Upgrade

via: SeekingAlpha at 2018-09-19 15:35:18:000

In this article I will first go into the basic principle behind the Magic Formula and the Value Investing approach: The Margin of Safety. I will describe in detail why a Margin of Safety is fundamental for becoming a successful investor, supplied with phrases from Benjamin Graham's famous book… read more...

The Magic Formula Needs An Upgrade

via: SeekingAlpha at 2018-09-19 15:35:18:000

In this article I will first go into the basic principle behind the Magic Formula and the Value Investing approach: The Margin of Safety. I will describe in detail why a Margin of Safety is fundamental for becoming a successful investor, supplied with phrases from Benjamin Graham's famous book… read more...

Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results

via: PR Newswire at 2018-09-13 07:30:00:000

CRANBURY, N.J. , Sept. 13, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems for the t… read more...

Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results

via: PR Newswire at 2018-09-13 07:30:00:000

CRANBURY, N.J. , Sept. 13, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems for the t… read more...

Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results

via: PR Newswire at 2018-09-13 07:30:00:000

CRANBURY, N.J. , Sept. 13, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems for the t… read more...

AMAG Pharmaceuticals: A Well-Positioned Player In The Pharmaceutical Space

via: SeekingAlpha at 2018-08-27 08:33:44:000

Editor's note: Seeking Alpha is proud to welcome Tien Duy Vo as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Due to nega… read more...

AMAG Pharmaceuticals: A Well-Positioned Player In The Pharmaceutical Space

via: SeekingAlpha at 2018-08-27 08:33:44:000

Editor's note: Seeking Alpha is proud to welcome Tien Duy Vo as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Due to nega… read more...

AMAG Pharmaceuticals: A Well-Positioned Player In The Pharmaceutical Space

via: SeekingAlpha at 2018-08-27 08:33:44:000

Editor's note: Seeking Alpha is proud to welcome Tien Duy Vo as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Due to nega… read more...

Antares Pharma: Proven Business Model Set To Move Much Higher

via: SeekingAlpha at 2018-08-20 07:49:28:000

Following a big move of Antares Pharma ( ATRS ) shares from about $2.00 at the beginning of 2018 to near $3.40 currently (70% gain) some investors may question the potential for further upside in the shares near term. However, near-term catalysts bode well for a continued rally through at leas… read more...

Antares Pharma: Proven Business Model Set To Move Much Higher

via: SeekingAlpha at 2018-08-20 07:49:28:000

Following a big move of Antares Pharma ( ATRS ) shares from about $2.00 at the beginning of 2018 to near $3.40 currently (70% gain) some investors may question the potential for further upside in the shares near term. However, near-term catalysts bode well for a continued rally through at leas… read more...

Antares Pharma: Proven Business Model Set To Move Much Higher

via: SeekingAlpha at 2018-08-20 07:49:28:000

Following a big move of Antares Pharma ( ATRS ) shares from about $2.00 at the beginning of 2018 to near $3.40 currently (70% gain) some investors may question the potential for further upside in the shares near term. However, near-term catalysts bode well for a continued rally through at leas… read more...

California Cryobank And Cord Blood Registry Combine To Create A Leading Life Sciences Platform

via: PR Newswire at 2018-08-06 16:45:00:000

LOS ANGELES , Aug. 6, 2018 /PRNewswire/ -- California Cryobank , the world's leading donor sperm and donor egg bank, announced today that it has been acquired by GI Partners, a private equity investment firm, from leading healthcare investors Longitude Capital and NovaQuest Capital…. read more...

California Cryobank And Cord Blood Registry Combine To Create A Leading Life Sciences Platform

via: PR Newswire at 2018-08-06 16:45:00:000

LOS ANGELES , Aug. 6, 2018 /PRNewswire/ -- California Cryobank , the world's leading donor sperm and donor egg bank, announced today that it has been acquired by GI Partners, a private equity investment firm, from leading healthcare investors Longitude Capital and NovaQuest Capital…. read more...

California Cryobank And Cord Blood Registry Combine To Create A Leading Life Sciences Platform

via: PR Newswire at 2018-08-06 16:45:00:000

LOS ANGELES , Aug. 6, 2018 /PRNewswire/ -- California Cryobank , the world's leading donor sperm and donor egg bank, announced today that it has been acquired by GI Partners, a private equity investment firm, from leading healthcare investors Longitude Capital and NovaQuest Capital…. read more...

AMAG Pharmaceuticals, Inc. (AMAG) CEO Bill Heiden on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-04 11:08:20:000

AMAG Pharmaceuticals, Inc. (AMAG) Q2 2018 Results Earnings Conference Call August 02, 2018 08:00 AM ET Executives Linda Lennox - VP, IR Bill Heiden - President and CEO Nik Grund - Chief Commercial Officer Ted Myles - CFO Analysts Jessica Fye - JP Morgan Kyung Yang - Jef… read more...

AMAG Pharmaceuticals, Inc. (AMAG) CEO Bill Heiden on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-04 11:08:20:000

AMAG Pharmaceuticals, Inc. (AMAG) Q2 2018 Results Earnings Conference Call August 02, 2018 08:00 AM ET Executives Linda Lennox - VP, IR Bill Heiden - President and CEO Nik Grund - Chief Commercial Officer Ted Myles - CFO Analysts Jessica Fye - JP Morgan Kyung Yang - Jef… read more...

AMAG Pharmaceuticals, Inc. 2018 Q2 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-08-02 14:31:36:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with their 2018 Q2 earnings Read more … read more...

AMAG Pharmaceuticals, Inc. 2018 Q2 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-08-02 14:31:36:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with their 2018 Q2 earnings Read more … read more...

AMAG Pharmaceuticals Q2 revenues up 12%

via: SeekingAlpha at 2018-08-02 11:02:07:000

AMAG Pharmaceuticals ( AMAG +9.2% ) Q2 results : Revenues: $146.3M (+12.2%); Makena: $105.2M (+2.4%); Feraheme/MuGard: $37.8M (+36.5%); Intrarosa: $3.2M. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Earnings news and commentary, Read more … read more...

AMAG Pharmaceuticals Q2 revenues up 12%

via: SeekingAlpha at 2018-08-02 11:02:07:000

AMAG Pharmaceuticals ( AMAG +9.2% ) Q2 results : Revenues: $146.3M (+12.2%); Makena: $105.2M (+2.4%); Feraheme/MuGard: $37.8M (+36.5%); Intrarosa: $3.2M. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Earnings news and commentary, Read more … read more...

AMAG Pharmaceuticals EPS of -$0.75

via: SeekingAlpha at 2018-08-02 07:06:40:000

AMAG Pharmaceuticals (NASDAQ: AMAG ): Q2 EPS of -$0.75 may not be comparable to consensus of -$0.37. More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

AMAG Pharmaceuticals EPS of -$0.75

via: SeekingAlpha at 2018-08-02 07:06:40:000

AMAG Pharmaceuticals (NASDAQ: AMAG ): Q2 EPS of -$0.75 may not be comparable to consensus of -$0.37. More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-08-01 17:30:46:000

AAON , AAWW , ABC , ACIW , ACOR , AET , AGIO , ALE , ALNY , AMAG , AMCX , APO , APRN , ARES , AROC , ARW , AVP , BCE , BDX , BLL , BSIG , CBM , CBRE , CBZ , CCOI , CDW , CEIX , CHD , CI , CJ , CLX , CNQ , CNSL , CNX , CNXM , COT , CRS , CTSH , DNOW , … read more...

AMAG Pharmaceuticals: Shift In Long Sentiment Following 60% Run Up

via: SeekingAlpha at 2018-07-19 16:33:12:000

The determining trait of the enterprising (or active, or aggressive) investor is his willingness to devote time and care to the selection of securities that are both sound and more attractive than the average. - Benjamin Graham, The Intelligent Investor Shares of AMAG Pharmaceutical… read more...

AMAG Pharmaceuticals: Shift In Long Sentiment Following 60% Run Up

via: SeekingAlpha at 2018-07-19 16:33:12:000

The determining trait of the enterprising (or active, or aggressive) investor is his willingness to devote time and care to the selection of securities that are both sound and more attractive than the average. - Benjamin Graham, The Intelligent Investor Shares of AMAG Pharmaceutical… read more...

AMAG Pharmaceuticals: Shift In Long Sentiment Following 60% Run Up

via: SeekingAlpha at 2018-07-19 16:33:12:000

The determining trait of the enterprising (or active, or aggressive) investor is his willingness to devote time and care to the selection of securities that are both sound and more attractive than the average. - Benjamin Graham, The Intelligent Investor Shares of AMAG Pharmaceutical… read more...

AMAG to divest Cord Blood Registry for $530M

via: SeekingAlpha at 2018-06-15 07:15:26:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has agreed to sell its Cord Blood Registry unit to private equity shop GI Partners for $530M in cash. Most of the proceeds will be used to pay off the remaining $475M of its 7.875% Senior Notes due 2023. More news on: AMAG Pharmaceuticals, Inc., Healt… read more...

AMAG to divest Cord Blood Registry for $530M

via: SeekingAlpha at 2018-06-15 07:15:26:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has agreed to sell its Cord Blood Registry unit to private equity shop GI Partners for $530M in cash. Most of the proceeds will be used to pay off the remaining $475M of its 7.875% Senior Notes due 2023. More news on: AMAG Pharmaceuticals, Inc., Healt… read more...

AMAG to divest Cord Blood Registry for $530M

via: SeekingAlpha at 2018-06-15 07:15:26:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has agreed to sell its Cord Blood Registry unit to private equity shop GI Partners for $530M in cash. Most of the proceeds will be used to pay off the remaining $475M of its 7.875% Senior Notes due 2023. More news on: AMAG Pharmaceuticals, Inc., Healt… read more...

AMAG to divest Cord Blood Registry for $530M

via: SeekingAlpha at 2018-06-15 07:15:26:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has agreed to sell its Cord Blood Registry unit to private equity shop GI Partners for $530M in cash. Most of the proceeds will be used to pay off the remaining $475M of its 7.875% Senior Notes due 2023. More news on: AMAG Pharmaceuticals, Inc., Healt… read more...

AMAG to divest Cord Blood Registry for $530M

via: SeekingAlpha at 2018-06-15 07:15:26:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) has agreed to sell its Cord Blood Registry unit to private equity shop GI Partners for $530M in cash. Most of the proceeds will be used to pay off the remaining $475M of its 7.875% Senior Notes due 2023. More news on: AMAG Pharmaceuticals, Inc., Healt… read more...

California Cryobank And Cord Blood Registry To Be Combined By GI Partners To Create A Leading Life Sciences Platform

via: PR Newswire at 2018-06-15 07:10:00:000

LOS ANGELES , June 15, 2018 /PRNewswire/ -- California Cryobank , the world's leading donor sperm and donor egg bank, announced today that it has signed a definitive agreement for GI Partners, a private equity investment firm, to acquire the company from leading healthcare investors… read more...

California Cryobank And Cord Blood Registry To Be Combined By GI Partners To Create A Leading Life Sciences Platform

via: PR Newswire at 2018-06-15 07:10:00:000

LOS ANGELES , June 15, 2018 /PRNewswire/ -- California Cryobank , the world's leading donor sperm and donor egg bank, announced today that it has signed a definitive agreement for GI Partners, a private equity investment firm, to acquire the company from leading healthcare investors… read more...

California Cryobank And Cord Blood Registry To Be Combined By GI Partners To Create A Leading Life Sciences Platform

via: PR Newswire at 2018-06-15 07:10:00:000

LOS ANGELES , June 15, 2018 /PRNewswire/ -- California Cryobank , the world's leading donor sperm and donor egg bank, announced today that it has signed a definitive agreement for GI Partners, a private equity investment firm, to acquire the company from leading healthcare investors… read more...

California Cryobank And Cord Blood Registry To Be Combined By GI Partners To Create A Leading Life Sciences Platform

via: PR Newswire at 2018-06-15 07:10:00:000

LOS ANGELES , June 15, 2018 /PRNewswire/ -- California Cryobank , the world's leading donor sperm and donor egg bank, announced today that it has signed a definitive agreement for GI Partners, a private equity investment firm, to acquire the company from leading healthcare investors… read more...

California Cryobank And Cord Blood Registry To Be Combined By GI Partners To Create A Leading Life Sciences Platform

via: PR Newswire at 2018-06-15 07:10:00:000

LOS ANGELES , June 15, 2018 /PRNewswire/ -- California Cryobank , the world's leading donor sperm and donor egg bank, announced today that it has signed a definitive agreement for GI Partners, a private equity investment firm, to acquire the company from leading healthcare investors… read more...

Tricida readies IPO

via: SeekingAlpha at 2018-06-05 13:33:03:000

South San Francisco, CA-based Tricida ( TCDA ) has filed a preliminary prospectus for a $150M IPO. More news on: Tricida, Inc., Keryx Biopharmaceuticals, Inc., Novo Nordisk A/S, Healthcare stocks news, IPOs, Read more … read more...

Tricida readies IPO

via: SeekingAlpha at 2018-06-05 13:33:03:000

South San Francisco, CA-based Tricida ( TCDA ) has filed a preliminary prospectus for a $150M IPO. More news on: Tricida, Inc., Keryx Biopharmaceuticals, Inc., Novo Nordisk A/S, Healthcare stocks news, IPOs, Read more … read more...

Tricida readies IPO

via: SeekingAlpha at 2018-06-05 13:33:03:000

South San Francisco, CA-based Tricida ( TCDA ) has filed a preliminary prospectus for a $150M IPO. More news on: Tricida, Inc., Keryx Biopharmaceuticals, Inc., Novo Nordisk A/S, Healthcare stocks news, IPOs, Read more … read more...

AMAG Pharma CEO sells shares

via: SeekingAlpha at 2018-06-05 09:51:27:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) CEO Dr. William Heiden yesterday sold 20K shares for $25 each. This reduced his holdings in the company by 6%. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more … read more...

AMAG Pharma CEO sells shares

via: SeekingAlpha at 2018-06-05 09:51:27:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) CEO Dr. William Heiden yesterday sold 20K shares for $25 each. This reduced his holdings in the company by 6%. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more … read more...

AMAG Pharma CEO sells shares

via: SeekingAlpha at 2018-06-05 09:51:27:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) CEO Dr. William Heiden yesterday sold 20K shares for $25 each. This reduced his holdings in the company by 6%. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more … read more...

Antares Pharma, Excellent Risk-Reward Profile

via: SeekingAlpha at 2018-05-22 14:26:54:000

In the aftermath of Antares Pharma ( ATRS ) falling from $4.09 in mid-October to $1.58 by mid-November 2017 after it was learned that the FDA had issued a CRL for the company's TRT (testosterone replacement therapy) drug Xyosted, the stock has made a slow comeback beginning in December to a cu… read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-05-21 08:19:20:000

AMAG Pharmaceuticals (NASDAQ: AMAG ) initiated with Market Perform rating and $26 (5% upside) price target at Leerink. More news on: AMAG Pharmaceuticals, Inc., Achillion Pharmaceuticals, Inc., Sabra Healthcare REIT, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Institutional Top Ideas Series: Opaleye Management

via: SeekingAlpha at 2018-05-17 01:52:55:000

In the last entry of this series, we took a look at top ideas from Ra Capital Management, the best performing fund weve come across so far with heavily concentrated positions in their top ideas. Going forward, I hope to continue to delve into the portfolios of successful hedge funds … read more...

AMAG Pharmaceuticals (AMAG) Presents At 43rd Annual Deutsche Bank Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-05-10 14:23:10:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with this Read more … read more...

AMAG Pharmaceuticals (AMAG) Presents At 43rd Annual Deutsche Bank Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-05-10 14:23:10:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with this Read more … read more...

AMAG Pharmaceuticals' (AMAG) CEO William Heiden on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-03 14:36:08:000

AMAG Pharmaceuticals, Inc. (AMAG) Q1 2018 Earnings Conference Call May 03, 2018, 08:00 ET Executives Linda Lennox - VP, IR & Corporate Communications William Heiden - CEO and Director Nicholas Grund - EVP & Chief Commercial Officer Julie Krop - EVP & Chief Medical O… read more...

AMAG Pharmaceuticals' (AMAG) CEO William Heiden on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-03 14:36:08:000

AMAG Pharmaceuticals, Inc. (AMAG) Q1 2018 Earnings Conference Call May 03, 2018, 08:00 ET Executives Linda Lennox - VP, IR & Corporate Communications William Heiden - CEO and Director Nicholas Grund - EVP & Chief Commercial Officer Julie Krop - EVP & Chief Medical O… read more...

AMAG Pharmaceuticals, Inc. 2018 Q1 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-05-03 14:18:58:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with their 2018 Q1 earnings Read more … read more...

AMAG Pharmaceuticals, Inc. 2018 Q1 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-05-03 14:18:58:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with their 2018 Q1 earnings Read more … read more...

AMAG Pharmaceuticals EPS of -$1.59

via: SeekingAlpha at 2018-05-03 07:06:48:000

AMAG Pharmaceuticals (NASDAQ: AMAG ): Q1 EPS of -$1.59 may not be comparable to consensus of -$0.54. More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

AMAG Pharmaceuticals EPS of -$1.59

via: SeekingAlpha at 2018-05-03 07:06:48:000

AMAG Pharmaceuticals (NASDAQ: AMAG ): Q1 EPS of -$1.59 may not be comparable to consensus of -$0.54. More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-05-02 17:30:55:000

AAON , AAWW , ABMD , ADNT , AER , AMAG , APLP , APO , APRN , ARES , AROC , ARW , AVP , AYR , BCE , BDX , BERY , BLL , BSIG , CAH , CBM , CCOI , CEIX , CFX , CHD , CI , CIM , CJ , CNQ , CNSL , CNX , CNXM , COT , CPG , DWDP , EEX , EPC , ERF , FMS , FMS… read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-05-02 17:30:55:000

AAON , AAWW , ABMD , ADNT , AER , AMAG , APLP , APO , APRN , ARES , AROC , ARW , AVP , AYR , BCE , BDX , BERY , BLL , BSIG , CAH , CBM , CCOI , CEIX , CFX , CHD , CI , CIM , CJ , CNQ , CNSL , CNX , CNXM , COT , CPG , DWDP , EEX , EPC , ERF , FMS , FMS… read more...

Reader Inquiry: Antares Pharma PDUFA Date In September, Is Stock A Buy Here?

via: SeekingAlpha at 2018-04-09 21:31:23:000

In the Marketplace service ROTY (Runners of the Year) , the material I write for subscribers is centered on holdings of the 10 stock model account and Contenders List. However, often ROTY members ask me about stocks that arent on my radar or that I havent revisited in a long ti… read more...

Reader Inquiry: Antares Pharma PDUFA Date In September, Is Stock A Buy Here?

via: SeekingAlpha at 2018-04-09 21:31:23:000

In the Marketplace service ROTY (Runners of the Year) , the material I write for subscribers is centered on holdings of the 10 stock model account and Contenders List. However, often ROTY members ask me about stocks that arent on my radar or that I havent revisited in a long ti… read more...

By The Numbers: Best Biotech Stocks

via: SeekingAlpha at 2018-04-05 06:47:07:000

Investing in biotech stocks can be a double-edged sword. When positioned in the right biotech names, investors can be rewarded with massive gains. On the other hand, the losses are also substantial if you pick the wrong stocks in the sector. There is no infallible formula to picking winning … read more...

By The Numbers: Best Biotech Stocks

via: SeekingAlpha at 2018-04-05 06:47:07:000

Investing in biotech stocks can be a double-edged sword. When positioned in the right biotech names, investors can be rewarded with massive gains. On the other hand, the losses are also substantial if you pick the wrong stocks in the sector. There is no infallible formula to picking winning … read more...

Looking For Action? S&P 1500 Most Volatile Stocks

via: SeekingAlpha at 2018-03-29 04:21:00:000

For traders with a short-term time horizon looking for big moves, we have updated our list of the S&P 1500 stocks trading above $10 that have the largest intraday high-low ranges (based on the average percent spread between the intraday high and low over the last 50 days). The stocks are g… read more...

AMAG Pharmaceuticals (AMAG) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-28 13:54:10:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with this Read more … read more...

Your Daily Pharma Scoop: Clovis Update, Novartis' MS Results, Vericel's SUMMIT Study

via: SeekingAlpha at 2018-03-26 08:00:00:000

Analysis focus: Clovis Oncology Today we will discuss Clovis Oncology (CLVS), which is up sharply after the obtained a positive opinion from the European Medicines Agencys ((EMA)) CHMP for Rubraca as a treatment for women with advanced BRCA mutant ovarian cancer with platinum-sensi… read more...

Biotech Forum Daily Digest For February 12th

via: SeekingAlpha at 2018-02-12 10:14:39:000

T here are some days we can claim and there are other days that claim us . Kamand Kojouri Investors got treated like 'rented mules' this week as the markets suffered their worst weekly loss in some two years. Four of the five trading sessions featured over 1,000 point sw… read more...

Biotech Forum Daily Digest For February 12th

via: SeekingAlpha at 2018-02-12 10:14:39:000

T here are some days we can claim and there are other days that claim us . Kamand Kojouri Investors got treated like 'rented mules' this week as the markets suffered their worst weekly loss in some two years. Four of the five trading sessions featured over 1,000 point sw… read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-02-09 12:34:12:000

Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-02-09 12:34:12:000

Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-02-09 12:34:12:000

Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-02-09 12:34:12:000

Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-02-09 12:34:12:000

Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more … read more...

3 Things In Biotech You Should Learn Today: February 6, 2018

via: SeekingAlpha at 2018-02-07 08:00:00:000

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotec… read more...

3 Things In Biotech You Should Learn Today: February 6, 2018

via: SeekingAlpha at 2018-02-07 08:00:00:000

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotec… read more...

3 Things In Biotech You Should Learn Today: February 6, 2018

via: SeekingAlpha at 2018-02-07 08:00:00:000

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotec… read more...

Your Daily Pharma Scoop: AMAG Gets Label Expansion For Feraheme, Bristol-Myers Squibb Reports Results, EyeGate Shares Tumble

via: SeekingAlpha at 2018-02-06 08:00:00:000

Analysis of top Seeking Alpha coverage: AMAG Pharmaceuticals Today we will discuss AMAG Pharmaceuticals ( AMAG ), which as expected got a nod from the FDA for expanded use of Feraheme (ferumoxytol injection) for all eligible adult patients with iron deficiency anemia ( IDA ) who are … read more...

FDA action date today for expanded use of AMAG Pharma's Feraheme; shares up 2%

via: SeekingAlpha at 2018-02-02 11:31:24:000

The FDA's action date (PDUFA) is today for its review of AMAG Pharmaceuticals' ( AMAG +1.5% ) marketing application seeking approval to use Feraheme (ferumoxytol) to treat all adults with iron deficiency anemia (IDA) who are intolerant of or fail to respond adequately to oral iron therapy…. read more...

FDA action date today for expanded use of AMAG Pharma's Feraheme; shares up 2%

via: SeekingAlpha at 2018-02-02 11:31:24:000

The FDA's action date (PDUFA) is today for its review of AMAG Pharmaceuticals' ( AMAG +1.5% ) marketing application seeking approval to use Feraheme (ferumoxytol) to treat all adults with iron deficiency anemia (IDA) who are intolerant of or fail to respond adequately to oral iron therapy…. read more...

FDA action date today for expanded use of AMAG Pharma's Feraheme; shares up 2%

via: SeekingAlpha at 2018-02-02 11:31:24:000

The FDA's action date (PDUFA) is today for its review of AMAG Pharmaceuticals' ( AMAG +1.5% ) marketing application seeking approval to use Feraheme (ferumoxytol) to treat all adults with iron deficiency anemia (IDA) who are intolerant of or fail to respond adequately to oral iron therapy…. read more...

FDA action date today for expanded use of AMAG Pharma's Feraheme; shares up 2%

via: SeekingAlpha at 2018-02-02 11:31:24:000

The FDA's action date (PDUFA) is today for its review of AMAG Pharmaceuticals' ( AMAG +1.5% ) marketing application seeking approval to use Feraheme (ferumoxytol) to treat all adults with iron deficiency anemia (IDA) who are intolerant of or fail to respond adequately to oral iron therapy…. read more...

AMAG Pharmaceuticals Could Be February's Breakout Biopharma Stock

via: SeekingAlpha at 2018-01-30 09:08:01:000

AMAG Pharmaceuticals ( AMAG ) has been beaten down nearly 40% in the past year, but is looking recover in February. Feraheme , which the FDA will decide the fate of on February 2nd, is currently approved for treatment of iron deficiency anemia in adults with chronic kidney disease. The com… read more...

AMAG Pharmaceuticals Could Be February's Breakout Biopharma Stock

via: SeekingAlpha at 2018-01-30 09:08:01:000

AMAG Pharmaceuticals ( AMAG ) has been beaten down nearly 40% in the past year, but is looking recover in February. Feraheme , which the FDA will decide the fate of on February 2nd, is currently approved for treatment of iron deficiency anemia in adults with chronic kidney disease. The com… read more...

AMAG Pharmaceuticals Could Be February's Breakout Biopharma Stock

via: SeekingAlpha at 2018-01-30 09:08:01:000

AMAG Pharmaceuticals ( AMAG ) has been beaten down nearly 40% in the past year, but is looking recover in February. Feraheme , which the FDA will decide the fate of on February 2nd, is currently approved for treatment of iron deficiency anemia in adults with chronic kidney disease. The com… read more...

Biotech Forum Daily Digest For January 29th

via: SeekingAlpha at 2018-01-29 10:22:44:000

Quality means doing it right when no one is looking . Henry Ford We saw two big acquisitions last week on Monday totaling just over $20 billion. To put this in perspective, acquisitions across the global Life Sciences sector, which includes pharma and biotech, rang up jus… read more...

Biotech Forum Daily Digest For January 29th

via: SeekingAlpha at 2018-01-29 10:22:44:000

Quality means doing it right when no one is looking . Henry Ford We saw two big acquisitions last week on Monday totaling just over $20 billion. To put this in perspective, acquisitions across the global Life Sciences sector, which includes pharma and biotech, rang up jus… read more...

Biotech Forum Daily Digest For January 29th

via: SeekingAlpha at 2018-01-29 10:22:44:000

Quality means doing it right when no one is looking . Henry Ford We saw two big acquisitions last week on Monday totaling just over $20 billion. To put this in perspective, acquisitions across the global Life Sciences sector, which includes pharma and biotech, rang up jus… read more...

AMAG Pharma sees Q4 revenue as high as $162M

via: SeekingAlpha at 2018-01-08 16:05:42:000

Ahead of its presentation tomorrow morning at JPM18, AMAG Pharmaceuticals ( AMAG +1.7% ) provides preliminary Q4 2017 and full-year results and guidance for this year. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more … read more...

AMAG Pharmaceuticals - Uncertainty Remains High Amidst Makena Expiration

via: SeekingAlpha at 2018-01-07 02:27:51:000

Exactly a year ago I checked on the prospects for AMAG Pharmaceuticals ( AMAG ) in an article in which I concluded that the exclusivity overhang of Makena created heightened uncertainty. The combination of the upcoming expiry for Makena in early 2018, AMAGs top selling drug, and a… read more...

2018 Biotech Investing Theme: Looking For Safety Plays

via: SeekingAlpha at 2018-01-03 13:48:41:000

When I look for biotech stocks to invest in, I typically look for two things. First, does the company's products and/or technology provide a meaningful advantage or advance over the competition. Second, is this a company that might be attractive to others as a potential acquisition target. If … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2017-12-07 09:08:26:000

Cancer Genetics (NASDAQ: CGIX ) initiated with Buy rating and $6 (179% upside) price target by Maxim Group. More news on: Cancer Genetics, Inc., AMAG Pharmaceuticals, Inc., Celldex Therapeutics, Inc, Healthcare stocks news, Read more … read more...

Your Daily Pharma Scoop: Valeant's B+L In India, TXMD's NDA Resubmission, Melinta Makes An Acquisition

via: SeekingAlpha at 2017-11-30 08:28:28:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Valeant B+L This is a tidy little art… read more...

Palatin Technologies Announces Signing of Licensing Agreement with Kwangdong Pharmaceutical for Republic of Korea

via: PR Newswire at 2017-11-21 07:30:00:000

CRANBURY, N.J. , Nov. 21, 2017 /PRNewswire/ --Palatin Technologies, Inc. (NYSE MKT: PTN; "Palatin") announced today that it has entered into a collaboration and license agreement with Kwangdong Pharmaceutical Co., Ltd. ("Kwangdong"), for exclusive rights to develop and commercialize… read more...

Antares Pharma On Sale

via: SeekingAlpha at 2017-11-14 10:18:32:000

Antares Pharma ( ATRS ) stock has experienced a severe drop in price since it received notification from the FDA that its testosterone drug Xyosted would not be approved in October, followed by a CRL one week later. From a recent high of $4.09 to a recent low of $1.58 (November 8), the stock h… read more...

The Sum Of All Fears For This Small Pharma

via: SeekingAlpha at 2017-11-10 13:45:00:000

It's been a wild ride for Antares Pharma ( ATRS ) investors over the past few months. As such, I'll do my best to provide a relatively comprehensive update on the company. As a little bit of warning to readers, I'm writing this article from the prospective that the reader is familiar with the … read more...

AMAG Pharmaceuticals, Inc. 2017 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2017-11-05 11:14:50:000

The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with their 2017 Q3 earnings Read more … read more...

AMAG Pharmaceuticals (AMAG) CEO Bill Heiden on Q3 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-11-05 11:10:06:000

AMAG Pharmaceuticals, Inc. (AMAG) Q3 2017 Earnings Conference Call November 2, 2017 09:00 a.m. ET Executives Bill Heiden - President, Chief Executive Officer Nik Grund - Chief Commercial Officer Ted Myles - Chief Financial Officer Linda Lennox - Vice President, Investor Relatio… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX